Vesalius Biocapital
Vesalius Biocapital Partners S.à r.l., founded in 2007 and based in Strassen, Luxembourg, is a venture capital and private equity firm focused on investing in life sciences and novel food applications. The firm targets all stages of development, including seed, early, mid, and late-stage ventures, with a particular emphasis on healthcare, pharmaceuticals, therapeutics, medtech, biotechnology, and nanotechnology. Vesalius Biocapital seeks to support companies that develop innovative drugs, medical devices, and diagnostics addressing unmet medical needs, as well as novel nutrition technologies for disease prevention and treatment. The firm primarily invests in Europe, concentrating on the Benelux countries, German-speaking regions, and Scandinavia, typically committing between €1 million and €5 million in each portfolio company, with the possibility of increasing this amount in subsequent rounds. Vesalius Biocapital usually takes minority equity stakes and plays an active role by leading or co-leading investment syndicates and securing board representation in its portfolio companies. With over €150 million under management across two funds, Vesalius has contributed to the development of 20 companies since its inception.
SWORD Health Lda. is a digital healthcare provider specializing in the treatment of musculoskeletal disorders through technology-driven solutions. Founded in 2012 and headquartered in Porto, Portugal, the company enables patients to undertake therapy in the comfort of their homes, effectively addressing chronic and post-surgical pain without the need for imaging, surgeries, or opioids. Since its launch in 2015, SWORD Health has partnered with insurers, health systems, and employers across Europe, Australia, and the United States, making its services accessible to a broad audience. The company combines the expertise of licensed physical therapists with innovative technology to deliver effective rehabilitation, aiming to alleviate pain for millions of people globally. SWORD Health maintains offices in New York City, Chicago, Salt Lake City, Sydney, and Porto.
SWORD Health Lda. is a digital healthcare provider specializing in the treatment of musculoskeletal disorders through technology-driven solutions. Founded in 2012 and headquartered in Porto, Portugal, the company enables patients to undertake therapy in the comfort of their homes, effectively addressing chronic and post-surgical pain without the need for imaging, surgeries, or opioids. Since its launch in 2015, SWORD Health has partnered with insurers, health systems, and employers across Europe, Australia, and the United States, making its services accessible to a broad audience. The company combines the expertise of licensed physical therapists with innovative technology to deliver effective rehabilitation, aiming to alleviate pain for millions of people globally. SWORD Health maintains offices in New York City, Chicago, Salt Lake City, Sydney, and Porto.
Tonic App S.A. is a digital health company that has developed a mobile application aimed at enhancing communication and collaboration among medical professionals. The application serves as a comprehensive platform for doctors to message, share, and archive patient cases, request expert advice, and network with peers. It also enables hospitals, pharmaceutical companies, and medical associations to connect with healthcare professionals and disseminate relevant medical content. Key features of the app include tools for coordinating urgent procedures, discussing clinical cases, sharing medical images, and accessing a range of healthcare resources, such as clinical calculators and drug conversion tables. Founded in 2016 and headquartered in Porto, Portugal, Tonic App strives to improve the efficiency of medical practice and patient outcomes through its integrated approach to health content aggregation and team collaboration. The application is available on Google Play.
SWORD Health Lda. is a digital healthcare provider specializing in the treatment of musculoskeletal disorders through technology-driven solutions. Founded in 2012 and headquartered in Porto, Portugal, the company enables patients to undertake therapy in the comfort of their homes, effectively addressing chronic and post-surgical pain without the need for imaging, surgeries, or opioids. Since its launch in 2015, SWORD Health has partnered with insurers, health systems, and employers across Europe, Australia, and the United States, making its services accessible to a broad audience. The company combines the expertise of licensed physical therapists with innovative technology to deliver effective rehabilitation, aiming to alleviate pain for millions of people globally. SWORD Health maintains offices in New York City, Chicago, Salt Lake City, Sydney, and Porto.